Publications by authors named "Wanbin Fu"

Claim this Profile
P
Prognostic Value of Dynamic Measurable Residual Disease Monitoring by Multiflowcytometry in Elderly Patients With Nonintensively Treated Acute Myeloid Leukemia.
Yue Sun, XiaoFeng Han, YiWei Zhang, WanBin Fu, Yi Fang

Clin Lymphoma Myeloma Leuk· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation.
Gelan Zhu, Jiayi Cai, Wanbin Fu, Yue Sun, Ting Wang

Hematology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia.
Gelan Zhu, Wenjing Lang, Wanbin Fu, Lan Xu, Jiayi Cai

Int Immunopharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells.
Wanbin Fu, Gelan Zhu, Lan Xu, Jia Liu, Xiaofeng Han

Cancer Cell Int· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homoharringtonine Synergized with Gilteritinib Results in the Downregulation of Myeloid Cell Leukemia-1 by Upregulating UBE2L6 in FLT3-ITD-Mutant Acute Myeloid (Leukemia) Cell Lines.
Jiayi Cai, Honghui Huang, Xiaoli Hu, Wenjing Lang, Wanbin Fu

J Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma.
Zi-Zhen Xu, Wan-Bin Fu, Zhen Jin, Pei Guo, Wen-Fang Wang

Leuk Lymphoma· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effect of oridonin and a PI3K/mTOR inhibitor on the non-germinal center B cell-like subtype of diffuse large B cell lymphoma.
Kai Qing, Zhen Jin, Wanbin Fu, Wenfang Wang, Zhao Liu

J Hematol Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma.
Zi-Zhen Xu, Wen-Fang Wang, Wan-Bin Fu, Ai-Hua Wang, Zhi-Yin Liu

Leuk Lymphoma· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis